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E2F transcription factors are thought to influence the
G1–S cell-cycle transition by controlling expression of
genes required for growth and DNA synthesis. But
emerging evidence suggests E2F complexes can control
the cell cycle independently of transcription by directly
regulating DNA replication origin usage during S phase.
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Numerous changes in the profile of transcribed genes
occur during progression through the eukaryotic cell cycle.
Many genes are coordinately expressed at only one phase
of the cell cycle, and these generally encode factors that
are involved in executing the events of that particular cell-
cycle phase. Consequently, these transcriptional programs
are thought to contribute in a major way to progression
through the cell cycle. One of the best known examples of
such a program occurs at the G1–S transition, the primary
proliferative control point for many cells. Work over the
past 15 years on animal systems has pointed to the E2F
family of transcription factors as key regulators of entry
into S phase. The most widely accepted model suggests
that E2Fs work exclusively by transcriptional regulation.
But recent studies with both Drosophila and cultured
mammalian cells hint at a direct involvement of E2F
complexes in regulating origins of DNA replication, which
is distinct from E2F’s ability to regulate transcription.
Here we highlight this novel function for E2F, and discuss
ways in which E2F-containing complexes could directly
regulate replication origin usage.
The protein dubbed ‘E2F’ is a heterodimeric transcription
factor containing a molecule of E2F bound to a molecule
of DP. In mammals, there are families of E2F and DP pro-
teins that have both specialized and redundant functions.
E2F–DP heterodimers are regulated mainly by association
with a member of the pRB family of tumor suppressor
proteins — pRB, p107 and p130 — each of which also has
both specialized and redundant functions. In spite of the
biological complexity generated by these gene families, a
unifying model of how these complexes control the cell
cycle has emerged. In the simplest version of the model,
E2F is both an activator and repressor of transcription.
Hypophosphorylated pRB binds to E2F in quiescent cells,
and this complex actively represses genes containing E2F
binding sites. These target genes fall into two categories:
first, those that encode the ‘nuts and bolts’ required for
DNA synthesis to initiate and proceed, such as ribonu-
cleotide reductase, DNA polymerase α, the origin recogni-
tion complex (ORC) and so on; and second, those that
encode direct regulators of cell-cycle transitions, such as
cyclin E, cyclin A and the cyclin-dependent kinases
(Cdks). When quiescent cells are stimulated to divide by
exposure to growth factors, pRB is hyperphosphorylated
by newly activated G1 cyclin-Cdk dimers and as a result
dissociates from E2F. This converts E2F from a transcrip-
tional repressor to a transcriptional activator, which induces
expression of both classes of target genes and thereby
stimulates entry into S phase.
This model is derived in large part from studies on
mammalian cells in culture, which are tremendously useful
for probing the biochemical and cellular activities of indi-
vidual molecules. But because this work often relies on
experiments testing the effects of overexpressing or
ectopically expressing some component, the connection to
normal events in intact animals is not always entirely clear.
Genetic studies in whole animals can bridge this gap.
Knockout mutations for each of the three pRB family
members, and for four of the six E2F family members,
have been generated in mice. Analyses of the phenotypes
caused by these mutations have supported the general
model of E2F function, and have also revealed that partic-
ular aspects of E2F function are carried out by individual
E2F proteins. 
The E2F-as-activator role is supported by the effects of
E2F-3 deficiency: mouse embryonic fibroblasts lacking
E2F-3 have a severe proliferative defect in culture [1].
Moreover, the magnitude of the growth defect in individ-
ual knockout cell lines correlates with the magnitude of
loss of E2F target gene expression. Genetic experiments
also support the E2F-as-repressor role. Mouse embryonic
fibroblasts lacking both E2F-4 and E2F-5 fail to growth
arrest in response to p16INK4A, a cyclinD–Cdk4 inhibitor
that keeps pRB in the active, hypophosphorylated state
[2]. Correspondingly, simultaneous loss of all three pRB
family members in cultured mouse embryonic fibroblasts
results in a shortened cell doubling time, causes a failure
to arrest the cell cycle in response to DNA damage,
cellular contact or serum starvation, and prevents cellular
senescence [3,4].
While these experiments provide important information
about how pRB–E2F complexes contribute to mammalian
development, cell-cycle control and tumorigenesis, out of
necessity much of the mechanistic data still come from
analyses of cultured cells. This is because many of these
mutations prevent normal development, and detailed cell
biological analysis in situ is not easy in mutant mouse
embryos. Drosophila provides distinct advantages in this
regard, where it is much easier to look at cellular pheno-
types in intact tissues. The pRB and E2F gene families
are conserved in flies, which have two members of each
family. In addition, the initial genetic data on Drosophila
E2F fit the current dogma [5]: mutation of dE2F or dDP
blocks expression of replication genes and compromises
cell proliferation, and loss of RBF function in embryos
causes transcriptional de-repression of E2F target genes
and escape from G1 arrest. In several situations, however,
dE2F mutant cells still replicate even when target gene
expression is absent or very low [5,6]. This challenges the
simplest version of the existing dogma, and raises the ques-
tion of whether there are additional ways that pRB–E2F
complexes affect DNA replication.
Just such a novel role for pRB–E2F was found by taking
advantage of the opportunity Drosophila provides to
examine the cell-cycle plasticity that occurs in all animal
development. Such plasticity arises from variation of what
we often consider a ‘normal’ cell cycle. For instance, early
embryonic divisions lack gap phases altogether, and G1
regulation does not appear until 8 hours of embryogenesis.
Thus, transcriptional regulation of the G1–S transition by
E2F is irrelevant in early fly development. Other cell-
cycle variations bypass what we often consider important
control mechanisms. Many cell types naturally become
polyploid during both insect and mammalian develop-
ment, and in Drosophila this is a particularly widespread
phenomenon. Polyploidization occurs through a special-
ized endoreduplication cycle in which there is no mitosis.
Instead, the cell alternates between G and S phase, result-
ing in polyploidy. Such cells thus bypass the mechanisms
that usually prevent re-replication and ensure the ‘once and
only once’ replication origin firing typical of a mitotic cycle.
Fundamental cell-cycle regulatory mechanisms are often
revealed by studying these seemingly unusual cell cycles.
In fact, the new role for pRB–E2F complexes became
apparent by examining a specialized cell cycle in the
Drosophila ovary. A Drosophila egg chamber contains a cyst
of 16 germ cells, one of which becomes the oocyte while
the remaining 15 become support cells. This germ cell
cyst is enclosed by an epithelium consisting of a single
layer of somatic follicle cells. The follicle cells execute a
unique cell-cycle program that provides an animal model
for exploring the mechanism of initiation of DNA replica-
tion [7]. Follicle cells proliferate mitotically during forma-
tion of the egg chamber. They then endoreduplicate their
DNA for four cycles, thus becoming polyploid. These
polyploid follicle cells then synchronously and selectively
amplify approximately 80-fold two chorion gene clusters
that encode egg shell proteins. Chorion gene amplification
provides the biosynthetic capacity necessary for rapid pro-
duction of the egg shell.
Many of the molecules and mechanisms that control
genomic replication during a typical S phase also control
chorion gene amplification [7]. The amplification occurs
by repeated re-initiation of an origin of replication within
the chorion gene cluster. While specific initiation sites in
animals have been hard to identify and so are in general
poorly defined, the chorion loci provide an exception. A
DNA fragment containing cis-acting elements sufficient to
support chorion gene amplification has been defined [8,9].
These elements bind to the ORC, a six subunit complex
necessary for the ordered recruitment of other trans-acting
factors needed for initiation, such as Cdc6, the MCM heli-
case complex and Cdc45. This pre-initiation complex is
activated in a still mysterious fashion by kinases such as
cyclin E–Cdk2 and Cdc7–Dbf4 [10].
Interestingly, pRB–E2F complexes are also required for
normal chorion gene amplification. While null alleles of
dE2F, dDP and RBF are lethal, weak alleles of these
three genes allow development and produce viable adult
flies. The mutant female flies are sterile, however,
because of defects in the follicle cells. The dE2F and
dDP mutants have decreased chorion gene amplification
and produce eggs with a thin shell [11]. Conversely, RBF
mutant follicle cells over-amplify the chorion genes [12].
How does E2F affect chorion gene amplification? Curi-
ously, even though it is well established in both flies and
mammals that E2F can control the transcription of genes
encoding ORC, MCM and Cdc6, the amplification defects
occur without obvious changes to the expression of E2F
target genes in the egg chambers. One possibility is that
pRB–E2F directly regulates some aspect of origin function.
Indeed, the ORC subunits Orc1 and Orc2 immunoprecipi-
tate with dE2F and RBF in ovary extracts, and chromatin
immunoprecipitations show that this complex is present at
the chorion locus in vivo [12].
One attractive feature of follicle cells is that the localized
replication at the chorion loci can be visualized in situ by
immunostaining [13]. Orc1, Orc2, Orc5 and Cdc45 are
each detected throughout the entire follicle cell nucleus
during genomic replication in endoreduplication cycles.
In contrast, these molecules localize specifically to the
chorion clusters during amplification, consistent with their
roles in initiation and progression of replication [11,14,15].
A mutant form of dE2F predicted to bind DNA poorly is
associated with a loss of ORC localization to amplification
foci [11], suggesting that an E2F-containing complex
might facilitate recruitment of ORC to the chorion locus.
Conversely, an allele of dE2F encoding a truncated
protein lacking the pRB-binding domain increases the
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level of amplification, without a detectable change in
ORC localization [11]. The truncated dE2F protein is
unable to bind to the ORC, even though the complex is
present at the origins in this mutant, pointing to RBF as a
mediator of the E2F–ORC interaction. These data
suggest that RBF–dE2F directly inhibits initiation at a
step after ORC binds DNA.
Are these phenomena simply an idiosyncrasy of Drosophila?
In a detailed look at replication in primary mammalian
cells by in situ immunofluorescence, Kennedy et al. [16]
found that pRB, p107 and p130 were enriched at localized
sites of DNA replication early in S phase. In addition,
expression of a constitutively active form of pRB, which
lacks the inactivating phosphorylation sites, was found to
inhibit progression through S phase in cultured cells inde-
pendently of effects on G1 control [17]. These data
suggest that mammalian pRB–E2F complexes may also
regulate S phase independently of transcription.
What mechanism could E2F complexes use to directly
regulate replication initiation? Potential answers to this
question may be found by considering the enzymatic
activities associated with E2F complexes. E2F associates
with histone acetyltransferases (HATs), and pRB with
histone deacetylases (HDACs) [18–20]. These enzymes
are best known for their role in controlling transcription by
altering chromatin structure: HAT activity promotes an
‘open’ chromatin configuration that allows recruitment of
transcription factors that activate transcription, while
HDAC activity promotes a ‘closed’ configuration that
represses transcription [21,22]. There is good evidence
that E2F and pRB family proteins regulate transcription
of E2F target genes by respectively recruiting HATs and
HDACs to alter chromatin structure [20,23]. A simple
extension of this idea to the recruitment and formation
of replication complexes might explain how pRB–E2F
complexes affect gene amplification (Figure 1).
Direct binding of pRB–E2F to the ORC raises a more
intriguing possibility, however. Recently it has become
apparent that acetylation regulates the activity of pro-
teins other than histones [22,24]. This group of proteins
consists mostly of transcription factors, but also includes
non-chromatin associated proteins. Acetylation modifies
protein activity, and some have suggested that acetyla-
tion/deacetylation may rival phosphorylation as a means of
controlling protein function [21,24]. Acetylation/deacety-
lation of certain transcription factors regulates their DNA
binding ability and their interactions with other proteins.
Importantly, the acetylation/deacetylation of these pro-
teins can be carried out by the same enzymes that act on
histones, for example PCAF, p300/CBP and HDAC1–4
[18,19,25]. The acetylation/deacetylation of ORC or other
replication proteins mediated by E2F-containing com-
plexes might therefore affect the ability of these factors to
interact with DNA or with each other (Figure 1). Indeed, a
likely histone acetyltransferase, HBO1, binds human
Orc1, although whether any replication factors are modi-
fied by HBO1 is not known [26]. All of these observations
suggest that perhaps the time is right to begin thinking of
E2F-containing complexes not simply as transcription
Figure 1
Two non-exclusive hypotheses for how
pRB–E2F complexes could directly regulate
replication origin firing without modulating
transcription. In the model illustrated on the
left, pRB bound to E2F recruits HDAC to the
chromatin, which deacetylates histones and
drives the chromatin into a configuration that
hinders access of replication factors to the
origin. In the opposite situation, HAT activity
associated with E2F causes histone
acetylation and a chromatin configuration that
allows the assembly of replication complexes
at the origin. In an alternative model illustrated
on the right, deacetylation of certain
components of the replication complex (RC)
by pRB–E2F-associated HDAC decreases
their association with either DNA or with each
other. Acetylation of these components by
HAT-bound E2F increases their DNA binding
ability and/or their affinity to each other,
facilitating the formation of the replication
complex at sites of replication initiation.
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factors, but as enzymes that can affect protein function
more directly.
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